Kimyrsa
Active substance: oritavancin diphosphate
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · ORITAVANCIN DIPHOSPHATE 1200 mg/40mL
United StatesActive
Marketing holder: Melinta Therapeutics, LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ORITAVANCIN DIPHOSPHATE · 1200 mg/40mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12090-bcd1-790e-81da-be6f872b8620;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 70842-225
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 70842-225 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 70842-225 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 70842-225 · Verified 2026-10-09 · open in source